News & events
Stay up-to-date with the latest developments and upcoming events in the world of gene transfer tools with our comprehensive news and events section.

Launches GMP production of mRNA technology for next-generation vaccines
Flash BioSolutions LAUNCHES GMP PRODUCTION OF REVOLUTIONARY mrna technology for next-generation vaccines and therapies Toulouse, Occitanie, France, 26 September 2024 […]
Learn More
Increase Gene Delivery RUO production capacity for C2 and C3 GMO-Level Viral Particles
Flash BioSolutions increases Gene Delivery RUO production capacity in France to meet surging demand for C2 and C3 GMO-Level Viral Particles Toulouse, […]
Learn More
Flash BioSolutions welcomes Stewart Craig to its esteemed Scientific Advisory Board
Flash BioSolutions welcomes Stewart Craig to its esteemed Scientific Advisory Board We are thrilled to announce the newest addition to […]
Learn More
Collaboration between CEA and FLASH Biosolutions for the development of cutaneous cell therapy
Collaboration between CEA and FLASH Biosolutions for the development of cutaneous cell therapy Flash Therapeutics celebrates a decade of collaboration […]
Learn More
Flash BioSolutions appoints Anne DEFLISQUE Business & Marketing Director
Flash BioSolutions appoints Anne DEFLISQUE Business & Marketing Director to boost growth We are thrilled to announce the newest addition […]
Learn More
KiraGen Bio and Flash BioSolutions announce innovative partnership to revolutionize CAR-T therapies for solid tumors
KiraGen Bio and Flash BioSolutions Announce Innovative Partnership to Revolutionize CAR-T Therapies for Solid Tumors KiraGen Bio and Flash BioSolutions […]
Learn More
Introducing Flash BioSolutions : Spearheading advancements in Biopharmaceutical CDMO sector
Introducing Flash BioSolutions : Spearheading advancements in Biopharmaceutical CDMO sector Flash BioSolutions® strengthens its position in the Contract Development and […]
Learn More
Flash BioSolutions obtains Pharmaceutical Establishment status, opening up new avenues for its revolutionary FlashRNA® technology
Flash BioSolutions obtains Pharmaceutical Establishment status, opening up new avenues for its revolutionary FlashRNA® technology The company’s recent achievement highlights […]
Learn More
LentiFlash® becomes FlashRNA®
Rebranding : LentiFlash® becomes FlashRNA® Announcement : Our unique patented technology, LentiFlash®, is to be rebranded as FlashRNA®. Why this […]
Learn More
Development of HPV16 mouse and dog models for more accurate prediction of human vaccine efficacy
Development of HPV16 mouse and dog models for more accurate prediction of human vaccine efficacy As observed with the COVID-19 […]
Learn More
Jérôme Bédier : CEO of Flash Therapeutics
Flash Therapeutics appoints Jérôme Bédier as Président to accelerate its biopharmaceutical CDMO business development Flash Therapeutics aims to accelerate its […]
Learn More